Single DermaVir Immunization in HIV-1 Infected Patients on HAART
NCT00712530
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infection
Interventions
BIOLOGICAL:
DermaVir
DRUG:
HAART
Sponsor
Genetic Immunity